Home / Products / Pharma / General / By Therapeutic Class / Antidiabetic

Glyza (Saxagliptin) is an oral anti-diabetic agent to improve glycemic control with type 2 diabetes mellitus. Available as 2.5 mg and 5 mg Tablet.

Insimet is a preparation of Metformin. It is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It is available as 500 mg, 850 mg tablet and Insimet XR 500 mg tablet

Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation.

Linagliptin and Metformin combination is used to treat high blood sugar levels caused by type 2 diabetes. Linagliptin helps to control blood sugar levels by increasing substances in the body that make the pancreas release more insulin. It also signals the liver to stop producing sugar (glucose) when there is too much sugar in the blood. Metformin reduces the absorption of sugar from the stomach, reduces the release of stored sugar from the liver, and helps your body use sugar better. This medicine does not help patients who have insulin-dependent or type 1 diabetes.

Sinazid (Gliclazide) is an anti-diabetic agents indicated for maturity onset diabetes mellitus (NIDDM). Available as tablet.

Taglimet is a preparation of Sitagliptin Phosphate (Monohydrate) USP 50 mg & Metformin HCl BP 500 mg & Sitagliptin Phosphate (Monohydrate) USP 50 mg & Metformin HCl BP 1000 mg Tablet. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.